Carregant...
Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
The phase 2 placebo‐controlled, double‐blind PLUTO trial characterized the pharmacokinetics of belimumab plus standard systemic lupus erythematosus (SLE) therapy in patients with childhood‐onset SLE (cSLE) and demonstrated similar efficacy and safety to that in adult SLE. Patients with active cSLE a...
Guardat en:
| Publicat a: | Clin Pharmacol Drug Dev |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246766/ https://ncbi.nlm.nih.gov/pubmed/33245847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.889 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|